substance p (5-11), pglu(5)-mephe(8)-megly(9)- has been researched along with flupenthixol in 1 studies
Studies (substance p (5-11), pglu(5)-mephe(8)-megly(9)-) | Trials (substance p (5-11), pglu(5)-mephe(8)-megly(9)-) | Recent Studies (post-2010) (substance p (5-11), pglu(5)-mephe(8)-megly(9)-) | Studies (flupenthixol) | Trials (flupenthixol) | Recent Studies (post-2010) (flupenthixol) |
---|---|---|---|---|---|
47 | 0 | 0 | 929 | 128 | 138 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altier, N; Stewart, J | 1 |
1 other study(ies) available for substance p (5-11), pglu(5)-mephe(8)-megly(9)- and flupenthixol
Article | Year |
---|---|
Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
Topics: Adrenergic Antagonists; Amphetamine; Analgesia; Analgesics, Opioid; Animals; Benzazepines; Dopamine Antagonists; Flupenthixol; Male; Morphine; Nucleus Accumbens; Peptide Fragments; Pyrrolidonecarboxylic Acid; Raclopride; Rats; Rats, Wistar; Salicylamides; Substance P; Ventral Tegmental Area | 1998 |